Page 275 - Clinical Small Animal Internal Medicine
P. 275

24  Congenital Heart Disease  243

               In  the author’s experience, right‐sided CHF will com-  The decision to operate or pursue transcatheter therapy
  VetBooks.ir  monly need higher doses of oral furosemide or an alter-  relates to the expertise of the veterinarian performing
                                                                  the procedure, anatomy of the defect, and client prefer-
               native diuretic such as torsemide due to the potential for
               intestinal edema causing decreased gastrointestinal
                                                                  erinary medicine, though retrospective data on PDA
               absorption. ACE inhibitors should always be used in the   ence. Prospective comparison studies are lacking in vet-
               treatment of chronic CHF to decrease RAAS activation   closure suggest comparable to improved outcomes from
               associated with advanced heart failure and diuretic   a  transcatheter approach compared to  surgery. Novel
               administration.                                    devices, such as the Amplatz™ canine ductal occluder,
                 Pimobendan has become standard of care in the treat-  have greatly improved the ease with which PDA occlu-
               ment of CHF secondary to acquired cardiac diseases,   sion can be performed from a transarterial approach
               such as dilated cardiomyopathy and chronic degenera-  (Figure 24.8). Gordon et al. showed complete PDA occlu-
               tive valve disease. While no definitive data are available   sion in 40 of 41 dogs treated by a transarterial canine‐
               on the use of pimobendan in congenital cardiac disease,   specific device with no perioperative mortality compared
               most cardiologists advocate its use with CHF due to   to a reported perioperative mortality of 2–8% in the sur-
                 diseases of volume overload such as PDA or mitral valve   gical literature during open PDA ligation [1].
               dysplasia. The administration of pimobendan as a treat-  The CHD conditions which currently have a well‐
               ment for CHF secondary to diseases of pressure overload   established surgical or interventional treatment option
               like  SAS  and  PS  is  becoming  more  commonplace.   include PDA, persistent right aortic arch (PRAA), and
               However, extralabel use of pimobendan should be done   PS. Dogs with VSD or ASD have been successfully
               cautiously in the setting of outflow tract obstruction due   treated by both surgical and interventional techniques
               to potential for increase in pressure gradient, wall stress,   and, though costly, open surgical repair and newer tran-
               and myocardial oxygen consumption. Consultation with   scatheter devices for closure of these defects may be
               a veterinary cardiologist is advised prior to pimobendan     considered for the motivated client. Cyanotic ToF dogs
               use in cases of SAS and PS with CHF.               can be palliated by surgical construction of a systemic‐
                                                                  to‐pulmonary anastamosis, typically a modified Blalock–
                                                                  Taussig  shunt, which improves  pulmonary blood flow
               Surgical and Interventional Therapy
                                                                  and lessens central cyanosis. Open‐heart repair of ToF
               Congenital heart disease can be palliated medically, as   has also been described in the dog. Atrioventricular
               noted above, but also may be treated by minimally inva-  valve dysplasia is seldom treated by surgical or interven-
               sive (interventional) or traditional surgical techniques   tional techniques but if a stenotic component is present,
               whenever possible. An accurate diagnosis of CHD is   balloon valvuloplasty of the tricuspid or mitral valve may
                 critical to appropriately guide therapy as some animals   be considered. Open surgical repair of a dysplastic valve
               can go on to live a normal life if treated early.  may also be considered for the motivated client.



               (a)                              (b)                              (c)




















               Figure 24.8  Fluoroscopic images obtained during transcatheter occlusion of PDA in a 2‐year‐old mixed‐breed dog. (a) A sheath has been
               advanced from the femoral artery to the thoracic aorta and injected contrast agent defines the ductus (asterisk) and the pulmonary trunk
               (PA). (b) The Amplatz™ canine ductal occluder (arrow) has been advanced through the same sheath and deployed across the ductus, with
               contrast showing complete ductal occlusion. (c) The wire attached to the Amplatz™ canine ductal occluder has been removed as well as
               the sheath, and the device (arrow) is left permanently in place.
   270   271   272   273   274   275   276   277   278   279   280